EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Urinary steroid metabolome, blood pressure and long-term renal outcomes in autosomal dominant polycystic kidney disease: a cross-sectional and 18-year longitudinal analysis of the SUISSE ADPKD cohort

Andreas Serra, Jana Henschkowski Serra, Maximilian Severin, Stefan Russmann

Research Connections · 2026-11-10

DOI: 10.1093/rescon/vmag210 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background and hypothesis Hypertension occurs early in autosomal dominant polycystic kidney disease (ADPKD) and is linked to activation of the renin–angiotensin–aldosterone system. Whether the urinary steroid metabolome—reflecting pre-receptor glucocorticoid and mineralocorticoid metabolism—differs from health, relates to blood pressure, or predicts long-term progression is unknown. Methods We studied 62 untreated patients with ADPKD from the single-centre SUISSE cohort and 20 healthy volunteers. The 24-hour urinary steroid metabolome was quantified by gas chromatography–mass spectrometry, indexing 11β-hydroxysteroid dehydrogenase activity (cortisol/cortisone, F/E), cortisol production and relative aldosterone excretion. Baseline values were linked to a registry (median follow-up 18.3 years). The primary outcome was the rate of decline in estimated glomerular filtration rate (eGFR; CKD-EPI 2021, linear mixed-effects models); secondary outcomes were total kidney volume (TKV) growth, a composite kidney end point (end-stage kidney disease [ESKD] or eGFR halving) and incident hypertension. Associations (per standard deviation) were adjusted for baseline eGFR, baseline TKV, age and sex. Results Steroid differences from controls were sex-specific: the cortisol/cortisone ratio (F/E) was lower in ADPKD men (0.76 versus 1.08; p = 0.003) and relative aldosterone excretion higher in women (p = 0.005). Over a median of 18.3 years (median TKV growth 5.9%/year), a higher baseline F/E was associated with faster kidney growth (adjusted β = +0.88%/year per standard deviation; p = 0.007; false-discovery rate q = 0.03). In contrast, no steroid index modified the rate of eGFR decline (median slope −2.3 mL/min/1.73 m²/year), nor predicted the composite kidney end point or incident hypertension after adjustment; crude inverse steroid–blood-pressure associations disappeared after sex adjustment, and creatinine-corrected salt intake predicted no outcome. Conclusions In ADPKD the urinary steroid metabolome differs from health in a sex-specific manner, and a higher cortisol/cortisone ratio is associated with faster kidney growth—an exploratory, hypothesis-generating signal. It does not, however, predict the rate of GFR decline, and sex is the dominant determinant of the steroid–outcome relationship.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →